loader
Please Wait
Applying Filters...

Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X

List of Certificates of Suitability (CEPs) for cep_2022_088___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 EDMOND PHARMA S.R.L. Paderno Dugnano IT (1)

filter

01 Isoprenaline hydrochloride (1)

filter

01 Sweden (1)

filter

01 Valid (1)

URL Supplier Web Content
CEP 2022-088 - Rev 00
Valid
Chemical
2024-05-15
1332
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for CEP 2022-088 - Rev 00 of Edmond Pharma S.r.l. Paderno Dugnano It

Looking for Certificates of Suitability (CEPs) for CEP 2022-088 - Rev 00 of Edmond Pharma S.r.l. Paderno Dugnano It 1

20

Edmond Pharma S.r.l. Paderno Dugnano It, based in Sweden, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Recipharm has the brightest minds in the CDMO industry, from early development to commercial manufacturing.

One of their significant offerings is Isoprenaline hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-088 - Rev 00

This Chemical Type CEP, issued on May 15, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 1332 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY